UnknownPhase 4

Chemoradiotherapy for Recurrent T1G3 Bladder Cancer

20 participantsStarted 2017-10

Plain-language summary

To evaluate the short term results of chemoradiation in case of T1G3 BC after BCG failure.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients with recurrent T1G3 bladder cancer after 6 doses of BCG consenting for chemoradiation and refusing radical cystectomy Exclusion Criteria: * Any patients with distant metastasis or positive LN on CT or MRI. * Patients unfit for chemoradiation

What they're measuring

Result of chemoradiation for recurrentT1G3 BC after BCG failure

Timeframe: followup within two years

Trial details

NCT IDNCT03274284

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-11

Contact for this trial

moktar dawood

+201009442860 mokhtardawood@yahoo.com

View on ClinicalTrials.gov More Bladder Cancer trials